Pancreatic Adenocarcinoma Metastatic Completed Phase 2 Trials for Gemcitabine (DB00441)

Also known as: Metastatic Pancreatic Adenocarcinoma / Pancreatic carcinoma metastatic

IndicationStatusPhase
DBCOND0060224 (Pancreatic Adenocarcinoma Metastatic)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03529175Scheduling Nab-paclitaxel With GemcitabineTreatment
NCT02195180Efficacy and Safety of L-asparaginase Encapsulated in RBC Combined With Gemcitabine or FOLFOX in 2nd Line for Progressive Metastatic Pancreatic CarcinomaTreatment
NCT00998322A Study of REOLYSIN® in Combination With Gemcitabine in Patients With Advanced Pancreatic AdenocarcinomaTreatment
NCT01124786A Study Comparing CO-1.01 With Gemcitabine as First Line Therapy in Patients With Metastatic Pancreatic Adenocarcinoma (LEAP)Treatment